The XEOMIN Difference

XEOMIN Is a Unique First-line Neuromodulator Therapy for Your Adult Patients With1:

  • Upper limb spasticity
  • Cervical dystonia
  • Blepharospasm
  • Chronic sialorrhea

XEOMIN is a clinically proven therapy that’s helped more than 3 million patients in over 70 countries worldwide for various conditions. That number continues to grow2

What's So Unique About XEOMIN?

Merz Commitment

  • XEOMIN was developed by Merz, a private, 5th generation, family-owned, specialty healthcare company that's dedicated to neurology and focused on advancing neuromodulator technology
  • XEOMIN was developed by Merz, a private, 5th generation, family-owned, specialty healthcare company that's dedicated to neurology and focused on advancing neuromodulator technology
The science behind XEOMIN®.

Science

  • XEOMIN features a unique molecular profile that was developed through state-of-the-art precise manufacturing1*
  • XEOMIN is the only clinically proven neuromodulator uniquely purified to remove unnecessary proteins *‡
Learn more about the science behind XEOMIN Path Created with Sketch.
  • XEOMIN features a unique molecular profile that was developed through state-of-the-art precise manufacturing1*
  • XEOMIN is the only clinically proven neuromodulator uniquely purified to remove unnecessary proteins *‡

Convenience

  • XEOMIN offers ease of dosing with multiple vial size options, and it doesn't require refrigeration prior to reconstitution
Learn more about the convenience of XEOMIN Path Created with Sketch.
  • XEOMIN offers ease of dosing with multiple vial size options, and it doesn't require refrigeration prior to reconstitution

Efficacy and Safety

  • Demonstrated to be noninferior to active comparator (Botox® [onabotulinumtoxinA]) in cervical dystonia and blepharospasm2†
  • Proven safe and effective in FDA-approved indications1
  • XEOMIN is the first and only FDA-approved botulinum toxin type A for adults with chronic sialorrhea1
  • Demonstrated to be noninferior to active comparator (Botox® [onabotulinumtoxinA]) in cervical dystonia and blepharospasm2†
  • Proven safe and effective in FDA-approved indications1
  • XEOMIN is the first and only FDA-approved botulinum toxin type A for adults with chronic sialorrhea1

Support

  • Through MERZ CONNECTTM, your patients can access the XEOMIN Patient Savings Program and other helpful resources
  • Through MERZ CONNECTTM, your patients can access the XEOMIN Patient Savings Program and other helpful resources

*The direct impact of the non-therapeutic proteins on long term safety or efficacy has not been established. Information about the unique XEOMIN manufacturing process and the properties of incobotulinumtoxinA is not intended to imply superiority over other botulinum toxin type A products.

The potency Units of XEOMIN are specific to the preparation and assay method utilized. They are not interchangeable with the other preparations of botulinum toxin products and, therefore, Units of biological activity of XEOMIN cannot be compared to or converted into Units of any other botulinum toxin products assessed with any other specific assay method.

“I found XEOMIN, a treatment that works for me and helps manage my upper limb spasticity.”

Ruben, adult upper limb spasticity patient treated with XEOMIN

Individual results may vary.

References

  1. XEOMIN® [Package insert]. Raleigh, NC: Merz Pharmaceuticals, LLC; 2019.
  2. Data on file. Raleigh, NC: Merz North America, Inc; 2019.